Barclays PLC Coh Bar, Inc. Transaction History

Barclays PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.34 - $1.0 $1,623 - $4,775	-4,775 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$0.96 - $1.62 $3,962 - $6,687	-4,128 Reduced 46.37%	4,775 $5,000
Q2 2021 Aug 13, 2021	SELL	$1.09 - $1.49 $21,879 - $29,908	-20,073 Reduced 69.27%	8,903 $12,000
Q1 2021 May 13, 2021	BUY	$1.26 - $2.02 $23,142 - $37,101	18,367 Added 173.13%	28,976 $39,000
Q4 2020 Feb 11, 2021	SELL	$0.9 - $1.54 $843 - $1,442	-937 Reduced 8.12%	10,609 $14,000
Q3 2020 Nov 12, 2020	SELL	$0.87 - $2.08 $7,906 - $18,903	-9,088 Reduced 44.04%	11,546 $11,000
Q2 2020 Aug 12, 2020	BUY	$1.08 - $4.0 $22,284 - $82,536	20,634 New	20,634 $32,000
Q3 2019 Nov 14, 2019	SELL	$1.3 - $1.76 $41,366 - $56,003	-31,820 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.63 - $3.3 $40,943 - $82,892	25,119 Added 374.85%	31,820 $55,000
Q1 2019 May 15, 2019	BUY	$2.95 - $4.16 $19,767 - $27,876	6,701 New	6,701 $22,000
Q4 2018 Feb 14, 2019	SELL	$2.97 - $4.52 $26,397 - $40,173	-8,888 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.13 - $6.84 $26,861 - $44,487	6,504 Added 272.82%	8,888 $38,000
Q2 2018 Aug 14, 2018	BUY	$4.44 - $10.4 $10,584 - $24,793	2,384 New	2,384 $15,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.28M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.